This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heston, W. D. W. Articles by Ratliff, T. L. Search for Related Content PubMed PubMed Citation Articles by Heston, W. D. W. Articles by Ratliff, T. L.

Effects of -Difluoromethylornithine and Recombinant Interferon-₂ on the Growth of a Human Renal Cell Adenocarcinoma Xenograft in Nude Mice

Urologic Oncology Research Laboratories, Department of Surgery, Division of Urology, Washington University School of Medicine at The Wohl Hospital, St. Louis, Missouri 63110 [W. D. W. H., J. F., R. E. T.], and Department of Surgery, Division of Urology, Washington University School of Medicine at The Jewish Hospital of St. Louis, St. Louis, Missouri 63110 [T. L. R.]

The effects of human recombinant interferon-₂ (IFN-₂) and -difluoromethylomithine (DFMO) as single agents and in combination were studied for efficacy against the renal cell adenocarcinoma (JDF-1) in an in vitro clonogenic assay and in vivo as xenografts in nude mice. In vitro studies showed dose-dependent inhibition of JDF-1 colony formation by IFN-₂. DFMO alone did not significantly inhibit colony formation even though ornithine decarboxylase activity was significantly inhibited. The combination of IFN-₂ and DFMO synergistically inhibited JDF-1 colony formation. The synergism was more readily observed at low IFN-₂ concentrations. In vivo studies showed a similar tumor growth inhibition pattern. JDF-1 tumors were implanted s.c. in nude mice, and drugs were administered continuously by Alza minipumps (IFN-₂) and in drinking water (DFMO) for 28 days. IFN-₂ alone significantly inhibited JDF-1 growth, while DFMO alone had no significant inhibitory effect. The combination of IFN-₂ and DFMO inhibited tumor growth in an apparent additive manner at the doses used. This was reflected in the mean tumor weights obtained at the termination of the experiment: control, 1484 ± 187 (S.E.) mg; DFMO only, 1106 ± 129 mg; IFN-₂ only, 941 ± 186 mg; and DFMO plus IFN-₂, 620 ± 109 mg. Assessment of mouse natural killer cell activity at the time of sacrifice showed that DFMO inhibited natural killer cell activity, while IFN-₂ had no effect. DFMO was observed to inhibit ornithine decarboxylase activity in JDF-1 tumors by 78%, IFN-₂ by 18%, and the combination by 78%. In addition, the drugs individually and in combination had similar inhibitory effects on JDF-1 spermidine content. One of the unexpected findings was the alteration in the spermine:spermidine ratio in the tumors treated with the combination of DFMO and IFN-₂. The ratio in this group decreased to 0.44, while ratios for control, IFN-₂ only, and DFMO only were 0.99, 0.66, and 0.88, respectively. These results clearly show that combined therapy with DFMO and IFN-₂ is more effective than is single-drug therapy. The mechanism by which these drugs coordinately inhibit tumor growth is unclear but appears to be associated with direct inhibition of tumor cell proliferation, possibly by modulation of polyamine metabolism.

¹ Recipient of partial support from Grant CA 33553 from the National Cancer Institute of the NIH.

² Present address: Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

³ Recipient of a fellowship from the National Kidney Foundation.

⁴ Recipient of partial support by Grant CA 28860 from the National Cancer Institute through the National Bladder Cancer Project. To whom requests for reprints should be addressed.

Received 2/ 6/84. Accepted 4/26/84.

This article has been cited by other articles:

				J. M. Arbeit, R. R. Riley, B. Huey, C. Porter, G. Kelloff, R. Lubet, J. M. Ward, and D. Pinkel Difluoromethylornithine Chemoprevention of Epidermal Carcinogenesis in K14-HPV16 Transgenic Mice Cancer Res., August 1, 1999; 59(15): 3610 - 3620. [Abstract] [Full Text] [PDF]